4//SEC Filing
Obenshain Andrew 4
Accession 0001562180-24-002306
CIK 0001293971other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:40 PM ET
Size
11.5 KB
Accession
0001562180-24-002306
Insider Transaction Report
Form 4
Obenshain Andrew
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-03-04$1.53/sh−6,095$9,311→ 279,998 total - Award
Stock Option (right to buy)
2024-03-01+650,000→ 650,000 totalExercise: $1.56Exp: 2034-03-01→ Common Stock (650,000 underlying)
Footnotes (3)
- [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- [F2]The range in prices for the transaction reported on this line was $1.52 to $1.55. The average weighted price was $1.5276. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]This stock option will vest over a four-year period at the rate of 25% on the first anniversary of March 1, 2024, and then in equal monthly installments for the remaining 36 months.
Issuer
bluebird bio, Inc.
CIK 0001293971
Entity typeother
Related Parties
1- filerCIK 0001839697
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:40 PM ET
- Size
- 11.5 KB